XT
VIGL

XTX Topco’s Vigil Neuroscience VIGL Stock Holding History

XTX Topco’s Portfolio VIGL Stock Details VIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-26,298
Closed – – 3846
2025
Q3 		$0 Buy
26,298
+14,771
+128% +$119K ﹤0.01% 3330
2025
Q2 		$91.6K Buy
+11,527
New +$51.7K ﹤0.01% 1899

XTX Topco's VIGL Position: Q4 2025 in Review

XTX Topco sold out of Vigil Neuroscience (VIGL) in Q4 2025, closing a stake of 26,298 shares.

XTX Topco first reported a position in VIGL in Q2 2025 and held it in 2 quarters. The position peaked at $91.6K in Q2 2025. 0 funds tracked by Wall St. Rank hold VIGL as of Q4 2025.

  • XTX Topco reported no remaining Vigil Neuroscience position as of Q4 2025 after selling out during the quarter.
  • XTX Topco sold 26,298 Vigil Neuroscience shares in Q4 2025.
  • XTX Topco first reported a position in Vigil Neuroscience in Q2 2025 and held it in 2 quarters.
  • XTX Topco's Vigil Neuroscience position peaked at $91.6K in Q2 2025.
  • 0 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q4 2025.

Based on XTX Topco's 13F filing for Q4 2025, filed 17 Feb 2026.